Aria CV, Inc. has developed an innovative device aimed at addressing pulmonary hypertension through a unique, non-electronic approach. The device consists of four primary components: a reservoir, a balloon, a narrow conduit for gas transfer, and a nitinol anchor that secures the balloon in place. This design is notable for its simplicity and elegance, as it operates solely based on the natural motion of the heart, eliminating the need for batteries, pumps, or electronic systems. This breakthrough technology represents a significant advancement in the management of pulmonary hypertension, focusing on a more natural and less invasive solution.

The device's functionality hinges on the interaction between the reservoir and the balloon, which allows for the movement of gas in response to cardiac motion. This mechanism is designed to provide therapeutic benefits without the complications often associated with traditional mechanical devices. As an investigational device, it is currently limited to clinical investigation under federal regulations, highlighting its potential for future applications in medical treatment. Aria CV, Inc. is committed to advancing this technology, which could transform the landscape of pulmonary hypertension management.

United States

Aria CV, Inc:   Improving the lives of patients suffering from the disease of pulmonary hypertension.

Aria CV, Inc.

Company Details